The per capita market value of Penicillins and Streptomycins in Chile exhibited a fluctuating trend from 2013 to 2023. The market experienced an upward trend until 2016, peaking at $4.10. This was followed by a decline, reaching a low of $3.54 in 2019, and fluctuating minimally thereafter. The year-on-year variation from 2022 to 2023 showed no change, maintaining a value of $3.56 per capita. The 5-year compound annual growth rate (CAGR) exhibited stability, indicating limited growth over this period. As of 2023, the market value stood at $3.56 per capita.
Future trends to watch include potential impacts from healthcare policy shifts, generic market expansions, and global market dynamics such as changes in raw material availability and pricing, which could influence market stability and growth prospects.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 14 | 14 Spain | 3.89 | 2023 | View data | ||
| 15 | 15 Poland | 3.78 | 2023 | View data | ||
| 16 | 16 Chile | 3.56 | 2023 | |||
| 17 | 17 Vietnam | 2.56 | 2023 | View data | ||
| 18 | 18 Bolivia | 2.5 | 2023 | View data | ||
